Fort Washington Investment Advisors Inc Meridian Bioscience Inc Transaction History

Fort Washington Investment Advisors Inc

  • $16 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 26, 2022
SELL
$30.9 - $33.55 $961,113 - $1.04 Million
-31,104 Reduced 4.86%
609,314 $19.2 Million
Q1 2022

May 03, 2022
BUY
$19.97 - $26.94 $3.95 Million - $5.32 Million
197,550 Added 44.61%
640,418 $16.6 Million
Q2 2021

Aug 09, 2021
BUY
$18.01 - $28.32 $7.98 Million - $12.5 Million
442,868 New
442,868 $9.82 Million

Others Institutions Holding VIVO

# of Institutions
10
Shares Held
113K
Call Options Held
0
Put Options Held
0
View Full List

About MERIDIAN BIOSCIENCE INC

VIVO Quotes by TradingView
  • Ticker VIVO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 43,748,000
  • Description
  • Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...
More about VIVO
Track This Portfolio

Track Fort Washington Investment Advisors Inc Portfolio

Follow Fort Washington Investment Advisors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fort Washington Investment Advisors Inc , based on Form 13F filings with the SEC.

News

Stay updated on Fort Washington Investment Advisors Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email